Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy
- PMID: 16038251
Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy
Similar articles
-
Daily multidrug therapy for leprosy; results of a fourteen-year experience.Int J Lepr Other Mycobact Dis. 1997 Mar;65(1):37-44. Int J Lepr Other Mycobact Dis. 1997. PMID: 9207752 Clinical Trial.
-
Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.Dermatol Ther. 2017 Jan;30(1). doi: 10.1111/dth.12414. Epub 2016 Aug 23. Dermatol Ther. 2017. PMID: 27549245 Review.
-
Histoid leprosy; report of three cases.Int J Lepr Other Mycobact Dis. 1999 Jun;67(2):174-6. Int J Lepr Other Mycobact Dis. 1999. PMID: 10472376 No abstract available.
-
Adverse effects from multi-drug therapy in leprosy: a Brazilian study.Lepr Rev. 2007 Sep;78(3):216-22. Lepr Rev. 2007. PMID: 18035772
-
[Immuno-allergic accidents with rifamipcin].Acta Leprol. 2001-2002;12(2):71-8. Acta Leprol. 2001. PMID: 12136739 Review. French.
Cited by
-
N-Pyrrylarylsulfones with High Therapeutic Potential.Molecules. 2017 Mar 9;22(3):434. doi: 10.3390/molecules22030434. Molecules. 2017. PMID: 28282943 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical